This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Leukocyte Adhesion Deficiency Type 1
Information about Leukocyte Adhesion Deficiency Type 1: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Leukocyte Adhesion Deficiency Type 1
Most recent studies have shown that Leukocyte Adhesion Deficiency Type 1 shares some biological mechanisms with allergy, bacterial-infections, congenital-combined-immunodeficiency, granulomatous-disease-chronic, granulomatous-disorder, immunologic-deficiency-syndromes, impaired-healing, infective-disorder, inflammation, leukocyte-adhesion-deficiency, leukocyte-adhesion-deficiency-syndrome, mycoses, primary-immune-deficiency-disorder, pseudomonas-infections, pyoderma, pyoderma-gangrenosum, skin-ulcer, tissue-adhesions, ulcer.
Among the many pathways, these few ones have gauged particular interests from scientists studying Leukocyte Adhesion Deficiency Type 1, and have been seen in publications frequently: B Cell Proliferation, Cell Activation, Cell Adhesion, Cell Growth, Cell Proliferation, Chemotaxis, Cytolysis, Hypersensitivity, Immune Response, Leukocyte Activation, Leukocyte Aggregation, Lymphocyte Proliferation, Neutrophil Activation, Phagocytosis, Respiratory Burst, Secretion, T Cell Activation, T Cell Proliferation, Tolerance Induction, Wound Healing
Quite a number of genes have been found to play important roles in Leukocyte Adhesion Deficiency Type 1, such as ABL1, CD34, CD4, CHAF1A, COL17A1, CTLA4, DLD, ICAM1, IL2, IL2RA, IL4, ITGAL, ITGAM, ITGAX, ITGB2, LAD1, LTBR, NOD2. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.